Malcolm J. Moore

机构：University Health Network, The Alfred Hospital, Princess Margaret Cancer Centre, University of Colorado Anschutz, University of Colorado Denver · ORCID：0009-0007-7493-3558

发表论文 555 篇 · 总被引 76171 次 · h-index 103

代表论文

• Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group (2023 · Journal of Clinical Oncology · 被引 278)
• Improvements in Survival and Clinical Benefit With Gemcitabine as First-Line Therapy for Patients With Advanced Pancreas Cancer: A Randomized Trial (2023 · Journal of Clinical Oncology · 被引 170)
• Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study (2023 · Journal of Clinical Oncology · 被引 47)
• Whole genome and transcriptome profiling in advanced pancreatic cancer patients on the COMPASS trial (2025 · Nature Communications · 被引 36)
• The association of health-care contact days with physical function and survival in CCTG/AGITG CO.17 (2024 · JNCI Journal of the National Cancer Institute · 被引 15)
• Transverse Colon Primary Tumor Location as a Biomarker in Metastatic Colorectal Cancer: A Pooled Analysis of CCTG/AGITG CO.17 and CO.20 Randomized Clinical Trials (2024 · Clinical Cancer Research · 被引 6)